Member Info for LGO-fan

https://oilnow.gy/featured/tt-exploration-in-decline-as-guyana-fast-becoming-regional-centre-of-attraction/

Further insight as to why entry into South-America is so interesting. Also, I believe companies like CERP now have more leverage during negotiations with T&T gov to lower tax regime; generally seen by the industry are prohibitive to investment

"Potential for low-cost entry into a discovered onshore oilfield with a detailed work programme for 2019-2021 submitted as part of the Company's bid. Announcement of new concession forecast for late Q3/early Q4 2019."

Also, rules on Closed Period:

"Close period
Before 3 July 2016, a period of time under the Model Code during which persons discharging managerial responsibilities of a listed company were prohibited from dealing in the company’s securities. The close periods were:
The period of 60 days immediately preceding a preliminary announcement of the company's annual results or, if shorter, the period from the relevant financial year end up to and including the time of the announcement; or
The period of 60 days immediately preceding the publication of its annual financial report or if shorter the period from the end of the relevant financial year up to and including the time of such publication; and
If the company reported on a half-yearly basis, the period from the relevant financial period end up to and including the time of such publication; and
If the company reported on a quarterly basis the period of 30 days immediately preceding the announcement of the quarterly results or, if shorter, the period from the relevant financial period end up to and including the time of the announcement."

So, if Q3 numbers are released say mid Oct, then the closed period would be roughly mid Sept-Mid Oct. Based on that, I believe it will be unlikely that the BOD can buy into CERP shares prior to the Saffron spud.

Rather a good sign, dare I say!!

Hi Stalin and Luther,
I spend my time on BB wishing nothing more than to make an amazing return on my investment. Than I read about your stories and quite frankly wonder what on earth I am wasting my time with. I really wish the best for you and your mum, and if I had the power to do it, I’d happily sell swop my dream ROI for your and your mum’s good health. I mean that!

All the best

At Troll Base camp as SP moves north :-)

I think if one of my shares went up with 30%, I would be doing a funky chicken too. But ignoring said rise, the fundamentals of PQE haven’t changed lately. So keep a cool head, Ors : I wish nothing more for all holders there than plenty of growth but allow me to remain more excited about Aogl :-)

don’t believe we have seen the end of the drop.

I think that is the VSA target

23% :-)

PQE is up 13 % ??

he meant to say "IKEA"....lol....

whilst they are not a public company I believe they are estimated to be worth more than $85bn. LLL comparing CERP to IKEA send a clear message: I have said this before, and I repeat: LLL is a massive supporter of CERP, but comparing it IKEA is too much of am obvious ramp! "Control your excitement a bit more please, LLL!"

Appreciate the insight but as an outsider, i don't see it that way at all. Had another look at the #cog website, last years account and I challenge you to find a clear and obvious message regarding Apple. It may be in there somewhere, but if I need to look for it...it means it is not part of the core strategy. That's where the money is, by partnering with the likes of Apple, not in clinical trial. This company IMHO will not get anywhere by sticking in the clinical trial comfy zone. Waste of time....look at the SP. I sold out in 2017 at 140p....look where it is now. I keep checking in but remain unimpressed. A shame, because expertise in cognitive health is a fantastic USP. Just feel they are not doing much with it.

why did you leave?

yes, but not the focus for them

Hi Helpful, what are your thoughts on the matter?

Of course it will be great to get amazing numbers in the reserve report. And of course the higher the better, but we don’t need massive numbers nor do I believe we will get them. We will hopefully have enough to get sufficient RBL to invest in the assets, and get to 300/400 bopd. That in addition to growing service division could transform this company and in turn be a great platform for further growth.

yes, but that investor probably wouldn't be offloading it he/she believed there was an exciting strategy, plan, investment case, blah-blah-blah (this is technical vocab...requires at least 2 MBA's to understand!!)... in the short, mid and long term.

If said investor had been convinced, said investor would be buying! Simples.

dammit, Ors, you beat me to it, lol. Good progress!

apologies ...Q4/2020 that is

totally agree. I wouldn’t bother until the hit B/E even; which they announced by Q4.

I will also need to be convinced about the strategy of the company. A couple of observations:

1. The pharmaceutical industry has had, and will continue to have M&A’s
2. Clinical development is risky: always is, and always will be.

So Cog, having used those 2 as an excuse for the latest performance, is exposed here and will continue to be unless they diversify

This brings me back to the strategy: surely the money in cognitive health is not in clinical trials but in prevention, diagnosis and management. Where are the big ideas to really go behind that?

Clinical trials are fine, helps them to build fantastic expertise in cognitive health but surely that is not where the big money is. This continues to amaze me about COG. Spot the gorilla!